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Abstract: Control points of normal thymopoiesis may provide
insights into strategies for interrupting cell interactions in thymomas
which appear to maintain active T cell production. Thymus produc-
tion of T cells represents one of two pathways by which peripheral
T cell populations are maintained or, if lost, regenerated. The
production of T cells by the thymus results from a series of thymus
epithelial cell (TEC) - thymocyte interactions from entry of thymo-
cyte precursors into the thymus to release of mature naïve single
positive T cells into the periphery. Within this series of interactions,
certain control points have been identified, all of which act through
TEC to modulate thymopoiesis.
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Thymomas are slow-growing primary tumors that arise fromthymic epithelial cells (TEC).1 Thymomas are well known
for their association with autoimmune disorders, such as myas-
thenia gravis, suggestive of thymoma-induced distortions in
central tolerance induction. This possibility has been raised
because the process of thymopoiesis continues in many thymo-
mas, reflecting the complex interdependency between thymo-
cytes and TEC. The neoplastic epithelial cells may continue to
express thymic epithelial markers, and thymocytes at all devel-
opmental stages can be found in thymoma.2 Indeed, myasthe-
nia gravis is more common in thymoma patients with a
greater retention of thymopoiesis, as assessed by a high
frequency of CD4CD8 thymocytes.2 Understanding the
role of the thymus in T-cell generation and homeostasis may
contribute in understanding the biologic effects of thymoma
and may identify potential points of intervention. Normal
thymopoiesis results from a full symbiosis of thymocytes and
TEC. The differentiation of cortical and medullary TEC
subpopulations is dependent on T-cell lineage commitment,
and the maturation of T cells, in turn, is dependent on TEC.
Therefore, this review will address factors that regulate nor-
mal thymopoiesis by acting through TEC.
T CELL HOMEOSTASIS: THYMIC-INDEPENDENT
AND THYMIC-DEPENDENT PATHWAYS
The generation and maintenance of T-cell populations
are governed by the interplay of thymic-dependent and thy-
mic-independent pathways (Figure 1). Residual T-cell popu-
lations proliferate in severely lympho-depleted hosts, filling
the available “space.” The space in this rapid, thymic-inde-
pendent peripheral expansion is defined by homeostatic cy-
tokines, such as interleukin (IL)-73 and IL-15. These cyto-
kines are constitutively produced at stable levels and
consumed by a large population of T cells. At low circulating
maintenance levels, these cytokines are critical for survival of
their target cells: naive CD4 and CD8 cells are reliant on IL-7
and memory/effector CD8 cells reliant on IL-15. When T
cells are severely depleted, however, the relative levels per
cell of these cytokines increase. Increased levels of these
cytokines not only support survival but also drive expansion
of their targeted cells.4 This rapid expansion of residual T
cells results in a population composed primarily of memory
and effector T cells, but limited by the antigen-response
repertoire of the original population.5
The second pathway is the thymic-dependent genera-
tion of new naive T cells from T-cell progenitors. In this
pathway, progenitors from the bone marrow mature into T
cells in the thymus and are exported into the periphery as
naive T cells. In younger individuals, thymopoiesis plays the
principle role in the recovery of T cells, rapidly resulting in a
stable population of naive cells with broad T-cell receptor
repertoire diversity. However, the efficiency and time course
of the thymic-dependent pathway are highly correlated with
the age of the individual.6 In middle-aged individuals, fewer
are capable of extensive T-cell recovery, even successful
thymopoietic recoveries require 2 to 3 years to complete and
may include fewer naive cells. The delay is caused by the
physiologic involution of the thymus with age. To regenerate
T-cell populations, the thymus must expand and thymopoietic
tissue must increase. Studies of long-term immune reconsti-
tution in adults demonstrate that thymic regeneration and
renewal of productive thymopoiesis occurs.6 The question
then posed is what factors define the space-limiting thymo-
poiesis and how this space is regulated.
*Experimental Transplantation and Immunology Branch, Center for Cancer
Research, NCI, Bethesda, Maryland; and †Medical Oncology Branch,
National Cancer Institute, Bethesda, Maryland.
Disclosure: The authors declare no conflicts of interest.
Address for correspondence: Ronald E. Gress, MD, National Cancer Insti-
tute, NIH, 10 Center Drive, Building 10, Room CRC3-3350, Bethesda,
MD 20892. E-mail: gressr@mail.nih.gov
Copyright © 2010 by the International Association for the Study of Lung
Cancer
ISSN: 1556-0864/10/0510-0273
Journal of Thoracic Oncology • Volume 5, Number 10, Supplement 4, October 2010 S273
ROLE OF THYMOCYTES AND TEC IN
THYMOPOIESIS
T-cell progenitors arise in the marrow from hematopoi-
etic stem cells. On leaving the marrow, T-cell progenitors
home to the thymus and enter through the vasculature at the
cortical medullary junction. The most immature thymocytes
are termed double negative cells (DN) due to a lack of
expression of CD4 or CD8. In the DN stage, subdivided into
DN1 to DN4, thymocytes increase in number, migrate out-
ward through the cortex, and undergo the gene rearrange-
ments needed to form the T-cell receptor (TCR)  and 
chains. Signaling through the rearranged TCR- chain trig-
gers the main proliferative expansion of thymocytes and
differentiation into CD4 and CD8 double-positive (DP) cor-
tical thymocytes. On final rearrangement of the TCR- chain
and surface expression of a complete TCR-, the DP cells
undergo positive selection, based on affinity for class II or
class I major histocompatibility complex molecules, into
single positive (SP) CD4 or CD8 T cells, respectively.
Cells that fail to complete TCR gene rearrangements or to be
positively selected die. The SP cells then migrate back
through the thymus to enter the medulla, where maturation
occurs. Here, SP T cells undergo a stringent negative selec-
tion to remove cells that are reactive to self antigens ex-
pressed by medullary TEC and dendritic cells. The T cells
that survive the selection processes in the cortex and medulla
then exit the thymus to join the naive T-cell population in the
periphery.
Interactions between developing thymocytes and TEC
control much of thymopoiesis. Entry of T-cell progenitors
depends on interaction between chemokine and adhesion
molecules on progenitors, such as CCR9 and P-selectin
glycoprotein ligand-1 (PSGL1), and the corresponding li-
gands (CCL25 and P-selectin) expressed by thymic stroma.7,8
T-cell lineage commitment and differentiation are reinforced
through the interaction of Notch receptors on DN thymocytes
and ligands expressed on stromal cells.9 Thymocyte migra-
tion across the thymus is controlled by chemokine signals in
the stroma.10 Cytokines secreted by TEC, such as IL-7,
support thymocyte survival at key checkpoints, such as the
transition from DN1 to DN2.11 Finally, thymic stroma is
critical to the positive- and negative-selection processes.
Cortical TEC expressing class I and II major histocompati-
bility complex molecules support positive selection of corti-
cal thymocytes into CD4 and CD8 SP T cells. Medullary
TEC and dendritic cells, expressing tissue antigens, support
negative selection of autoreactive thymocytes and the devel-
opment of T-regulatory cells.12,13 Thus, all steps in thymo-
poiesis depend on interaction of thymocytes and TEC.
Yet, this interaction is not unidirectional. After the fetal
organogenesis period, the continued maintenance of cortical
and medullary TEC in the adult requires the presence of
functional thymocytes. Thymuses in which T-cell develop-
ment is blocked at the earliest DN1 stage show an absence of
both cortical and medullary TEC.14 Conversely, introducing
functional T-cell progenitors to a mouse in which thymocyte
differentiation is blocked at an early stage can trigger the
expansion and growth of TEC.15 These results demonstrate
that interactions between thymocytes and TEC are not limited
to the organogenesis period. A key finding is that TEC
populations are not static, but rather continuously differenti-
ating from TEC progenitors, expanding, and turning over.16
Thymocytes are constantly being renewed by an input of
T-cell progenitors. The interdependence of thymocytes and
TEC may contribute to their mutual decline with aging. Yet,
this same interdependence may underlie the ability of thy-
muses to renew growth and expand.
To further explore these interactions, studies have ad-
dressed several known components that influence thymus
function. Experiments on insulin-like growth factor (IGF)-1,
androgen signaling, and keratinocyte growth factor (KGF)
have been carried out to study their effects on thymopoiesis
and to determine the cellular and molecular basis of those
effects (Figure 2).
IGF-1 IN THYMOPOIESIS
Thymopoiesis can be significantly affected by systemic
hormones, such as the growth hormone (GH)/IGF-1 axis.
Declines in GH during adult life may contribute to the slow
decline in thymopoiesis. Most of the actions of GH are
carried out by IGF-1, which is generated in the liver in
response to GH. Treatment with either GH or IGF-1 consis-
tently produces an increase in thymic cellularity and periph-
eral T-cell levels.17 Identifying the effects of IGF-1 within the
thymopoietic process poses a challenge because IGF-1 recep-
tor (IGF-1R) is widely expressed among the subpopulations
of interest: T-cell progenitors, thymocytes, TEC, and mature
T cells.
Administering exogenous IGF-1 in thymus intact mice
elicited an increase in the number of naive T cells and recent
thymic emigrant populations in the periphery. Yet, similar
treatment in thymectomized mice did not alter peripheral
lymphocyte numbers. This supports that IGF-1 has an influ-
ence on the thymus-dependent pathway rather than the thy-
mus-independent pathway.
FIGURE 1. Thymus-independent and -dependent pathways
for reestablishing T-cell homeostasis differ between children
and adults.
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In vitro, IGF-1 enhanced proliferation and inhibits
apoptosis of T cells.18 In vivo, systemic treatment with
exogenous IGF-1 increased the numbers of T-cell progenitors
(LinSca-1c-kit) in both the marrow and the circulation.17
Increased thymopoiesis could be due to an enlarged precursor
population and increased entry into the thymus. Therefore,
the effects of IGF-1 on thymic function were tested in PSGL1
knockout mice (PSGL-1KO). Because P-selectin is involved
in T-precursor uptake into the thymus, these mice have a
severe limitation in thymocyte precursor importation. If
IGF-1 mediated its effect of enhancing thymopoiesis through
increased entry of precursors, then the effect should be
blunted in such mice. However, this was not observed exper-
imentally. Instead, administration of IGF-1 in the PSGL-1KO
mice increased thymopoiesis as it did in controls. Therefore,
the main target of IGF-1 was not impacted by limiting the
T-cell precursor pool.
The final determination was whether IGF-1 acted pri-
marily on thymocytes or TEC. Both populations increased
after systemic IGF-1 treatment and both showed increases in
the frequency of proliferating cells. Therefore, a transgenic
mouse model was developed with a T-lineage-specific knock-
out of the IGF-1 receptor (T-IGF-1R) on thymocytes and
mature T cells; IGF-1 receptor expression was retained on
TECs and T-cell progenitors. Treatment with IGF-1 produced
comparable increases in thymocytes in the mice lacking the
IGF-1R on thymocytes, as in those with the receptor present.
Therefore, the key factor was the expression of IGF-1R on
TEC. IGF-1 acted primarily by stimulating proliferative ex-
pansion of TEC. This increase in cortical and medullary TEC
then, in turn, supported an increase in thymocyte populations.
Thymopoietic space was regulated by stimulating TEC with
IGF-1.
ANDROGEN SIGNALING IN THYMOPOIESIS
In contrast to IGF-1, androgens are negative regulators
of thymopoiesis. Castration or androgen withdrawal results in
an enlargement of the thymus and an increase in thymic
T-cell generation.19,20 Furthermore, transplant studies have
demonstrated enhanced thymic size and cellularity, and in-
creased numbers of peripheral recent thymic emigrants, after
androgen withdrawal. As in the case of IGF-1, both TEC and
thymocytes express androgen receptors, but the TEC have
again been implicated as the controlling element in androgen
regulation of thymopoiesis. When androgen receptors on
TEC were dysfunctional, the effects of androgens on thymo-
cytes were abrogated.21
At issue then was which of the multiple thymopoiesis-
supporting functions of TEC was critical to the increase in
thymic productivity. Androgen withdrawal increased the
medullary and cortical epithelial cell areas, which, as noted,
play many roles in thymopoiesis. One of the earliest effects
was an increase in early T-lineage progenitors (ETP), the
earliest thymocyte precursor to enter the thymus. This in-
crease was found to be due to improved ETP immigration by
comparing update of adoptively transferred congenic T pro-
genitors in intact and castrated hosts. Finally, this increased
uptake was associated with an increase in TEC production of
CCL25, a chemokine critical for T progenitor entry and
migration in the thymus. Blockade of CCL25-ETP interac-
tions with antibody prevented the increase in thymopoiesis.20
Hence, androgen withdrawal triggered increases both in TEC
numbers and in TEC production of CCL25. These changes in
TEC then both enhanced the influx of ETP and supported
increased thymopoietic space.
KERATINOCYTE GROWTH FACTOR IN
THYMOPOIESIS
KGF is another factor that enhances thymic productiv-
ity and peripheral naive T-cell populations in intact mice, but
does not affect peripheral T cells in thymectomized mice.
KGF belongs to a family of structurally related fibroblast
growth factors and acts as an epithelial cell mitogen. KGF
FIGURE 2. Thymus recovery is regulated at different points by factors such as IGF-1, androgen signaling, and KGF. KGF, ker-
atinocyte growth factor; IGF, insulin-like growth factor.
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binds to the fibroblast growth factor receptor-2 of the IIIb
variant (FgfR2IIIb). In the thymus, FgfR2IIIb is exclusively
expressed on thymic epithelial stromal cells.22,23 In murine
studies, the addition of exogenous KGF rapidly triggered
proliferative expansion of TEC and TEC progenitors.22 KGF
treatment increased the uptake of labeled T progenitors, that
is the number of engraftment niches,22 although whether this
was the result of the same induction of TEC chemokines as
androgen withdrawal has not been tested. Furthermore, the
increase in ETP and TEC numbers resulted shortly afterward
in a wave of proliferative expansion in thymocytes and
subsequent export of naive T cells.22 Even in aged mice, KGF
treatment increased thymopoietic capacity and reversed in-
volutional changes.24 Repeated monthly KGF treatments pro-
longed these effects and reversed involution in aged murine
thymic structure, returning the thymuses to the size of those
in young adults.24 Therefore, KGF seems to play a major role
in regulating the niche size defined by TECs in the thymic-
dependent pathway.
An interesting aspect of KGF is that thymocytes pro-
duce KGF at specific stages of thymus development.23 There-
fore, KGF is an intrinsic factor to the thymus, rather than a
systemic one. KGF is not detectable in DN, but the level of
KGF expression proportionally increases with thymocyte
maturation. These findings also point up the interconnections
between thymocytes and TEC. Recombination activating
gene knockout (RAG/) thymocytes, perhaps because they
are arrested before the DP stage, do not produce KGF.23 The
RAG/ medullary region is rudimentary and disorganized.
This region can be induced to develop normal structure either
by transplant of normal hematopoietic stem cells,25 or by
treatment with KGF.23 These linkages between thymocytes
and TEC illustrate the interdependence of these populations.
SUMMARY
The finding that IGF-1, cessation of androgen signal-
ing, and KGF all act at the level of TECs identifies these cells
as playing a central role in the regulation of thymopoiesis.
The direct linkages between expansion of TEC populations
and increases in thymocytes suggest that these interactions
underlie the maintenance of thymopoiesis in thymomas. Con-
sidering that the mechanism common to these three model
systems is regulation of TEC proliferation, the identification
of genes that may be generally expressed in cells or specific
to TECs and are involved in regulation of cell division may
be of special interest in understanding the biology of thymo-
mas. Further, the association of autoimmunity with the ap-
parent continued production of T cells and their export to the
periphery poses questions concerning alterations in TEC/
T-cell interactions in thymomas.
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